Oslo, 6 April 2017: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2016.
The annual accounts and annual report for the financial year 2016 are enclosed with this notification and made available on the company's website, www.photocure.com.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no
About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company and world leader in photodynamic technology. Based on its unique proprietary Photocure Technology® platform, Photocure develops and commercializes highly selective and effective solutions in disease areas with high-unmet medical need, such as bladder cancer, HPV and precancerous cervical lesions, and skin conditions. Photocure's aim is to provide solutions which can improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). Information about Photocure is available at www.photocure.com.
